House Committee Requests Unpublished Pediatric Antidepressant Data
This article was originally published in The Pink Sheet Daily
Executive Summary
Lilly, GlaxoSmithKline, Pfizer and Wyeth are asked to submit unpublished pediatric antidepressant data to House Committee by Feb. 17. Letter cites FDA review of suicidality data for children on antidepressants.